Clinical Trials on Stage IIIC Hepatocellular Carcinoma in Switzerland
Total 81 results
-
University Hospital Inselspital, BerneCompletedHepatocellular CarcinomaSwitzerland
-
University of BernCompleted
-
University Hospital, GenevaUnknown
-
University of ZurichCentre Hospitalier Universitaire VaudoisTerminated
-
Naik Vietti VioliRecruitingHepatocellular Carcinoma | Magnetic Resonance Imaging | Screening | Contrast-enhanced USSwitzerland
-
Terumo Europe N.V.Federation Francophone de Cancerologie Digestive; Fundacion Clinic per a la...Completed
-
Swiss Group for Clinical Cancer ResearchActive, not recruiting
-
GuerbetCompletedHepatocellular CarcinomaGermany, Switzerland, Korea, Republic of, Austria
-
TheraOpAstraZenecaActive, not recruitingStage III Non-small Cell Lung Cancer | Locally Advanced | UnresectableSwitzerland
-
Pasche, Boris, M.D.Barbault, Alexandre, M.S.TerminatedCarcinoma, HepatocellularSwitzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Teratoma | Stage II Malignant Testicular Germ Cell Tumor | Stage III Malignant Testicular Germ Cell Tumor | Childhood Embryonal Tumor | Childhood Extracranial Germ Cell Tumor | Childhood Extragonadal Germ Cell Tumor | Childhood Malignant Ovarian Germ Cell Tumor | Childhood Malignant Testicular... and other conditionsUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
University Hospital, GenevaSuspendedStage IB Skin Melanoma | Stages III Skin Melanoma | Stages II Skin MelanomaSwitzerland
-
University Hospital Inselspital, BerneCompletedAdult Liver CancerSwitzerland
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Frontier Science Foundation, HellasCompletedNon-small Cell Lung Cancer Stage IIISwitzerland, Netherlands, Spain, Belgium, Germany
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedHepatocellular CarcinomaUnited States, Switzerland, Germany, France, Italy, Netherlands, Saudi Arabia, Turkey
-
Blueprint Medicines CorporationCompletedHepatocellular Carcinoma (HCC)China, Korea, Republic of, Taiwan, Hong Kong, United Kingdom, United States, France, Spain, Switzerland, Singapore, Germany, Italy
-
Terumo Europe N.V.CompletedHepatocellular Carcinoma | Metastatic CancerNetherlands, Germany, Switzerland, Belgium, Spain, Portugal, Italy
-
University of ZurichUnknownColorectal Neoplasms | Pancreatic Neoplasms | Cholangiocarcinoma | Hepatocellular CancerSwitzerland
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedPrimary Liver CancerAustria, Switzerland, France, Germany
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Hepatocellular CarcinomaUnited States, China, Italy, Japan, Korea, Republic of, Poland, Spain, Switzerland, Taiwan
-
University of ZurichWithdrawnHepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma | Liver MetastasisSwitzerland
-
AmgenCompletedCompletely Resectable Stage IIIB, IIIC, or IVM1a MelanomaUnited States, Poland, France, Russian Federation, Spain, Australia, Greece, Switzerland, Brazil
-
ETOP IBCSG Partners FoundationRoche Pharma AGActive, not recruitingEGFRmutant Stage IIIB/C or IV Non-squamous NSCLCSingapore, Spain, Korea, Republic of, Switzerland, Germany
-
Goethe UniversityActive, not recruitingAnal Cancer | Anal Carcinoma | Anal Cancer Stage III | Anal Cancer Stage IIGermany, Switzerland, Austria
-
Hoffmann-La RocheRecruitingUnresectable Hepatocellular CarcinomaCanada, France, Korea, Republic of, China, Japan, Spain, Belgium, Croatia, Brazil, Austria, Italy, Costa Rica, Germany, Israel, Thailand, Turkey, Russian Federation, United Kingdom, Taiwan, Philippines, India, Chile, Finland, Greece, Sl... and more
-
AmgenNo longer availableUnresected Stage IIIB to IVM1c MelanomaSwitzerland
-
University of ZurichCompletedMelanoma Stage III or IV | No Prior ChemotherapySwitzerland
-
Oncology Institute of Southern SwitzerlandEnte Ospedaliero Cantonale, Bellinzona; Clinical Trial Unit Ente Ospedaliero... and other collaboratorsActive, not recruitingNSCLC Stage IVSwitzerland
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaItaly, United States, Spain, China, Korea, Republic of, Taiwan, France, Japan, Germany, Belgium, Austria, Brazil, Czechia, Canada, Poland, United Kingdom, Israel, Australia, Hong Kong, Switzerland
-
Martin-Luther-Universität Halle-WittenbergRadiation Oncology Working Group of the German Cancer SocietyCompletedNon Small Cell Lung Cancer Stage IIIGermany, Austria, Belgium, Spain, Switzerland
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedHepatocellular CarcinomaUnited States, France, Italy, Germany, Spain, Switzerland, Belgium, Portugal, Netherlands, Australia, Brazil, Canada, Austria, New Zealand, Sweden, Argentina
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHepatocellular CarcinomaUnited States, Australia, Austria, Belgium, Canada, China, Czechia, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaUnited States, Canada, Belgium, Germany, Israel, Korea, Republic of, Spain, Australia, Austria, Brazil, France, Italy, Japan, Portugal, Taiwan, Romania, Bulgaria, Czech Republic, Finland, Hong Kong, Hungary, Netherlands, Norway, Phili... and more
-
Bristol-Myers SquibbActive, not recruitingHepatocellular CarcinomaGermany, Romania, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, France, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland and more
-
European Institute of OncologyActive, not recruitingEarly Stage Breast CarcinomaItaly, Chile, Spain, Switzerland
-
ExelixisActive, not recruitingHepatocellular CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czechia, France, Georgia, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Philippines, ... and more
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
Basilea PharmaceuticaCompletedIntrahepatic Cholangiocarcinoma | Combined Hepatocellular and CholangiocarcinomaCanada, United States, Spain, Belgium, Italy, Korea, Republic of, Germany, Switzerland, France, United Kingdom, Ireland
-
Dr Jean Yannis PERENTESRecruitingCarcinoma, Non-Small-Cell Lung | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Mesothelioma, Malignant | Carcinoma Breast Stage IVSwitzerland
-
BayerCompletedCarcinoma, HepatocellularJapan, Turkey, Austria, Czechia, Hungary, Israel, Russian Federation, Slovakia, Switzerland, India, Korea, Republic of, France, Mexico, Indonesia, Singapore, Thailand, Canada, Greece, Netherlands, Spain, Taiwan, Poland, Brazil, China, D... and more
-
University of Lausanne HospitalsCompletedIndocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With HepatocarcinomaCarcinoma, Hepatocellular | Alcoholic Cirrhosis | Viral Cirrhosis | Postoperative Hepatic FailureSwitzerland
-
Merck Sharp & Dohme LLCActive, not recruitingHepatocellular CarcinomaUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, New Zealand, Norway, Poland, Russian Federation, Spai... and more
-
Kliniken Essen-MitteGerman Breast GroupCompletedEarly-Stage Breast CarcinomaGermany, Switzerland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
Swiss Group for Clinical Cancer ResearchRecruitingNon-small Cell Lung Cancer (NSCLC) | Stage IVSwitzerland
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMelanoma Stage IV | Melanoma Stage IIIAustria, Germany, Switzerland
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Switzerland